Kuano
The startup combines quantum physics, artificial intelligence (AI) and medicinal chemistry in a unique approach to transforming the discovery of therapeutics focused on enzyme inhibition.
Kuano has raised €3.3M across 2 funding rounds from 6 investors, most recently a Seed round in Sep 2023. Based in London, UK; active in Deeptech. Data as of 28 Oct 2026.
London, UKwww.kuano.ai ↗
Total raised
€3.3M
€3,255,845
Funding rounds
2
Investors
6
distinct backers
Active since
2021-07
latest 2023-09
Funding by year
EUR raised per yearKuano — funding by year — interactive chart.
Data table
| Kuano — funding by year | |
|---|---|
| 2021 | €1.2M |
| 2023 | €2.1M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Seed
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-09-12 | Seed | €2.1M | ACF investors,Angel Investors,Ascension VC,Meltwind Advisory LLP,Mercia Ventures,o2h Ventures | View deal → |
| 2021-07-08 | Seed | €1.2M | ACF investors,o2h Ventures | View deal → |
Investors
6Related news
- UK biotech startup Kuano lands £1M for AI-driven drug discoveryuktech.news · 2021-07
- tech.eu
Similar companies
same sector or countryGlobal coverage: FundingData